Clelia Irrissuto

Anti-tumour activity of tachykinin NK1 receptor antagonists on human glioma U373 MG xenograft

Carla Palma, Mario Bigioni, Clelia Irrissuto et al. · British Journal of Cancer · 2000 · 69 citations · Full text

Molecular Pharmacology, Neuro-oncology, Medicine +13

Role of NK-1 and NK-2 tachykinin receptor antagonism on the growth of human breast carcinoma cell line MDA-MB-231

Mario Bigioni, Alfredina Benzo, Clelia Irrissuto et al. · Anti-Cancer Drugs · 2005 · 59 citations

Specific Receptor Antagonists, Breast Oncology, Nk-2 Receptor Antagonists +13

Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft

Mario Bigioni, Alfredina Benzo, Clelia Irrissuto et al. · Cancer Chemotherapy and Pharmacology · 2007 · 24 citations

Medicine, Pharmacology, Pathology +10

Synthesis and biological evaluation of rebeccamycin analogues modified at the imide moiety

Fabio Animati, Marco Berettoni, Mario Bigioni et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 13 citations

Medicinal Chemistry, Bioorganic Chemistry, Imide Moiety +12